ValenTx valentx.com


Public lists: Medical Devices (6123)

ValenTx is developing a new therapy to treat patients with obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. The company's technology mimics the therapeutic mechanisms of a Roux-en-Y gastric bypass, and does this with a non-surgical, endoluminal bypass device.

ValenTx is developing a new therapy to treat patients with obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. The company's technology mimics the therapeutic mechanisms of a Roux-en-Y gastric bypass, and does th...Show all

Company (Alive / Active)

Phone: 805-566-0700

Fax:

6901 East Fish Lake road
Suite 118
Osseo, 55369
Minnesota, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ValenTx $47.3M Aug 16, 2018
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ValenTx Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors

Competitors

Company Status Description Investors

IntraPace

San Jose, California, United States
Alive / ActiveIntraPace has developed an implantable system to treat obesity. The abiliti system is designed to be implanted via standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any limitations on what a person can eat or drink. IntraPace's abiliti system is designed to be an intelligent obesity intervention. Once implanted and activated, the abiliti system is designed to detect when a person consumes food or drink. When food or drink is detected, ...Show allLogin to see details

EndoGastric Solutions

Redmond, Washington, United States
Alive / ActiveEndoGastric Solutions, formerly EsophyX, is developing an endoscopic medical device and procedure that can quickly restore the competency of the anti-reflux barrier, which is distorted in GERD patients and contributes to acid reflux and regurgitation. EsophyX is based on EGS' NOS (Natural Orifice Surgery) platform technology. Designed specially for performing incisionless reconstructive gastrointestinal procedures, the device is introduced into the body through the mouth, rather than through an ...Show allLogin to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Apparatus and methods for treatment of morbid obesity Aug 02, 2016 Dec 12, 2017 Patent
Devices and methods for gastrointestinal bypass Mar 13, 2014 Sep 12, 2017 Patent
Devices and methods for gastrointestinal bypass May 17, 2013 Jun 20, 2017 Patent
Devices and methods for gastrointestinal bypass Jun 26, 2014 Jun 13, 2017 Patent
Devices and methods for gastrointestinal bypass May 31, 2012 Feb 14, 2017 Patent
See all 35 patents